S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:VTGN

VistaGen Therapeutics SEC Filings & 10K Form

$2.13
-0.07 (-3.18 %)
(As of 03/5/2021 05:28 PM ET)
Add
Compare
Today's Range
$1.96
Now: $2.13
$2.24
50-Day Range
$1.89
MA: $2.25
$2.96
52-Week Range
$0.30
Now: $2.13
$3.18
Volume2.91 million shs
Average Volume4.63 million shs
Market Capitalization$301.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.52

SEC Filings

VistaGen Therapeutics (NASDAQ:VTGN) SEC Filings

DateFilerForm TypeView
03/05/2021
3:43 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
3:38 PM
VistaGen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/02/2021
4:17 PM
VistaGen Therapeutics (Issuer)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
4:13 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2021
4:26 PM
Rosalind Advisors, Inc. (Filed by)
VistaGen Therapeutics (Subject)
Form SC 13G/A
01/06/2021
3:05 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
3:48 PM
SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:47 PM
GIN JERRY B (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
5:00 AM
Growth Equity Opportunities 17, LLC (Filed by)
VistaGen Therapeutics (Subject)
Form SC 13D
12/31/2020
4:21 PM
VistaGen Therapeutics (Filer)
Form PRE 14A
12/22/2020
3:17 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
5:38 AM
VistaGen Therapeutics (Subject)
Form FWP
12/17/2020
4:13 PM
VistaGen Therapeutics (Filer)
Form 424B5
11/12/2020
3:36 PM
VistaGen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/18/2020
3:56 PM
Rosalind Advisors, Inc. (Filed by)
VistaGen Therapeutics (Subject)
Form SC 13G
09/18/2020
8:14 AM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2020
3:31 PM
SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
4:24 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
3:26 PM
VistaGen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2020
8:56 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2020
7:45 PM
VistaGen Therapeutics (Filer)
Form 424B5
07/27/2020
3:52 PM
VistaGen Therapeutics (Filer)
Form DEFA14A
07/27/2020
3:51 PM
VistaGen Therapeutics (Filer)
Form DEF 14A
07/24/2020
5:03 AM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2020
4:35 PM
SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:33 PM
Smith Mark Alan (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:28 PM
DOTSON JERROLD DUANE (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
4:20 PM
Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2020
3:16 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2020
4:27 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2020
4:15 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
11:15 PM
VistaGen Therapeutics (Filer)
Form EFFECT
04/14/2020
11:15 PM
VistaGen Therapeutics (Filer)
Form EFFECT
04/03/2020
4:15 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
4:28 PM
VistaGen Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/26/2020
6:05 AM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2020
3:39 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2020
11:12 AM
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
VistaGen Therapeutics (Subject)
Form SC 13G/A
01/31/2020
4:25 PM
VistaGen Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/31/2020
4:22 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2020
5:02 AM
Lincoln Park Capital Fund, LLC (Filed by)
VistaGen Therapeutics (Subject)
Form SC 13G
01/24/2020
4:01 PM
VistaGen Therapeutics (Filer)
Form 424B5
12/27/2019
3:05 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
4:14 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
6:52 PM
SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
6:46 AM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
4:02 PM
DOTSON JERROLD DUANE (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
MCPARTLAND MARK A. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
Smith Mark Alan (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:01 PM
Cunningham Ann Michelle (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:00 PM
Underdown Brian J. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:00 PM
GIN JERRY B (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2019
4:00 PM
SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2019
11:15 PM
VistaGen Therapeutics (Filer)
Form EFFECT
09/30/2019
9:44 PM
VistaGen Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/30/2019
4:31 PM
VistaGen Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/25/2019
3:03 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
3:55 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:37 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
3:06 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
3:11 PM
VistaGen Therapeutics (Filer)
Form DEFA14A
07/25/2019
3:08 PM
VistaGen Therapeutics (Filer)
Form DEFA14A
07/23/2019
4:12 PM
VistaGen Therapeutics (Filer)
Form DEF 14A
07/23/2019
3:31 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
4:20 PM
VistaGen Therapeutics (Filer)
Form PRE 14A
06/25/2019
3:17 PM
VistaGen Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/21/2019
4:00 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2019
3:20 PM
SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:18 PM
GIN JERRY B (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:17 PM
Underdown Brian J. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:12 PM
Smith Mark Alan (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:10 PM
MCPARTLAND MARK A. (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:09 PM
DOTSON JERROLD DUANE (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
3:07 PM
Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
4:22 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
3:10 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
4:22 PM
SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
4:12 PM
SNODGRASS H. RALPH (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:50 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
3:15 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
3:36 PM
VistaGen Therapeutics (Filer)
Form 424B5
02/25/2019
3:40 PM
VistaGen Therapeutics (Filer)
Form 424B5
02/12/2019
3:34 PM
VistaGen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/08/2019
1:01 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
VistaGen Therapeutics (Subject)
Form SC 13G/A
01/30/2019
3:05 PM
SAXE JON S (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
3:29 PM
Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
3:16 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2019
8:55 PM
Singh Shawn (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
8:55 PM
Cunningham Ann Michelle (Reporting)
VistaGen Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
8:50 PM
Cunningham Ann Michelle (Reporting)
VistaGen Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2019
4:30 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
12:58 PM
SABBY MANAGEMENT, LLC (Filed by)
VistaGen Therapeutics (Subject)
Form SC 13G/A
12/17/2018
9:25 AM
VistaGen Therapeutics (Filer)
Form CT ORDER
12/13/2018
4:00 PM
VistaGen Therapeutics (Filer)
Form 8-K/A
10/30/2018
3:37 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:30 PM
VistaGen Therapeutics (Filer)
Form 10-Q/A
10/29/2018
3:16 PM
VistaGen Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2018
3:21 PM
VistaGen Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.